Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BAX
REST API REST API
Homo sapiens
BAX is differentially expressed in 297 experiments: 119 organism parts: bone marrow, lung, ... (117 more);, 214 disease states: normal, acute myeloid leukemia, ... (212 more);, 86 cell types 318 cell lines 43 compound treatments and 71 other conditions.
Synonyms BCL2L4
Orthologs BAX (2 of 2) (Danio rerio)   baxa (Danio rerio)   BAX_BOVIN (Bos taurus)   ENSCING00000013537 (Ciona intestinalis)   Bax (Mus musculus)   D4A9I1_RAT (Rattus norvegicus)   Bax (Rattus norvegicus)   bax (Xenopus laevis)   NP_001003011.1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, mitochondrial fusion, positive regulation of developmental pigmentation, endoplasmic reticulum, protein binding, apoptosis, response to wounding, cytoplasm, response to salt stress, cell proliferation, intracellular, negative regulation of cell proliferation, response to toxin, membrane, protein homooligomerization, lipid binding, spermatogenesis, activation of caspase activity, male gonad development, activation of caspase activity by cytochrome c, positive regulation of apoptosis, mitochondrial outer membrane, pore complex, soluble fraction, response to ionizing radiation, identical protein binding, sex differentiation, induction of apoptosis, germ cell programmed cell death, regulation of cell cycle, spermatid differentiation, nucleus, response to axon injury, protein heterodimerization activity, germ cell development, mitochondrial membrane, channel activity, post-embryonic development, nervous system development, protein homodimerization activity, DNA fragmentation involved in apoptotic nuclear change, response to DNA damage stimulus, response to gamma radiation, retinal cell programmed cell death, endoplasmic reticulum membrane, fertilization, neuron apoptosis, negative regulation of anti-apoptosis, cleavage of lamin, mitochondrion, regulation of apoptosis, negative regulation of neuron apoptosis, neuron migration, positive regulation of B cell apoptosis, B cell negative selection, myeloid cell homeostasis, regulation of mammary gland epithelial cell proliferation, activation of pro-apoptotic gene products, negative regulation of survival gene product expression, post-embryonic camera-type eye morphogenesis, negative regulation of fibroblast proliferation, blood vessel remodeling, negative regulation of protein binding, protein insertion into mitochondrial membrane involved in induction of apoptosis, positive regulation of release of sequestered calcium ion into cytosol, limb morphogenesis, establishment or maintenance of transmembrane electrochemical gradient, kidney development, B cell homeostatic proliferation, cerebral cortex development, regulation of neuron apoptosis, hypothalamus development, apoptotic mitochondrial changes, induction of apoptosis by intracellular signals, glycosphingolipid metabolic process, positive regulation of apoptosis involved in mammary gland involution, apoptosis in response to endoplasmic reticulum stress, B cell homeostasis, retina development in camera-type eye, ovarian follicle development, positive regulation of calcium ion transport into cytosol, BH3 domain binding, development of secondary sexual characteristics, regulation of protein heterodimerization activity, homeostasis of number of cells within a tissue, leukocyte homeostasis, release of cytochrome c from mitochondria, regulation of mitochondrial membrane potential, cellular response to UV, Sertoli cell proliferation, induction of apoptosis by extracellular signals, cytosolic part, regulation of protein homodimerization activity, response to acid, reduction of endoplasmic reticulum calcium ion concentration, negative regulation of peptidyl-serine phosphorylation, positive regulation of neuron apoptosis, induction of apoptosis in response to chemical stimulus, transformed cell apoptosis, odontogenesis of dentine-containing tooth, regulation of nitrogen utilization, vagina development, B cell apoptosis, regulation of mitochondrial membrane permeability, homeostasis of number of cells, release of matrix enzymes from mitochondria, nuclear fragmentation involved in apoptotic nuclear change, T cell homeostatic proliferation, mitochondrial permeability transition pore complex, mitochondrial fragmentation involved in apoptosis, induction of retinal programmed cell death, regulation of cysteine-type endopeptidase activity involved in apoptotic process, Bcl-2 family protein complex
InterPro Term Bcl2_BH, Bcl2-like_apoptosis
UniProt Accession Q8WXU1, Q07812, Q9UEI8, Q5ZPJ1, Q5ZPJ0, O95074
Search EB-eye ENSG00000087088
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-1577, E-GEOD-3526, E-MTAB-62, ... (25 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-18005, ... (45 experiments)

Factor Value U/D Experiments
MCF-7
1
3
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081, E-GEOD-5823
SNU1
2
E-GEOD-15460, E-MTAB-37
AGS
2
E-MTAB-37, E-GEOD-15460
HL-60
2
E-GEOD-5258, E-GEOD-24147
MCF7
2
E-GEOD-5258, E-MTAB-37
MDA468
2
E-MTAB-62, E-MEXP-440
312 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-GEOD-3920, E-GEOD-4219, E-GEOD-20677, ... (41 experiments)

Factor Value U/D Experiments
bronchial epithelial
2
E-AFMX-5, E-MTAB-25
neutrophil
2
E-GEOD-995, E-GEOD-3982
embryonic stem cell
2
E-MEXP-930, E-GEOD-26672
fibroblast
2
E-GEOD-26672, E-GEOD-3920
spermatocyte
1
E-TABM-130
CD3- CD56bright CD62L+ NK cell
1
E-GEOD-21774
80 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-1577, E-MEXP-2280, ... (62 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
3
E-MTAB-62, E-GEOD-2514, E-MEXP-231
prostate carcinoma
3
E-MEXP-2034, E-GEOD-96, E-MTAB-62
mesothelioma
2
E-MTAB-62, E-MTAB-37
Emery-Dreifuss muscular dystrophy
2
E-MTAB-62, E-GEOD-3307
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
colon carcinoma
1
2
E-MTAB-62, E-GEOD-3726, E-MTAB-37
208 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-6907, E-GEOD-5741, E-GEOD-15205, E-GEOD-697, ... (24 experiments)

Factor Value U/D Experiments
none
1
7
E-GEOD-412, E-GEOD-5824, E-GEOD-5099, E-MEXP-1958, E-GEOD-2803, ... (8 experiments)
U0126
1
E-GEOD-697
phoshate buffered saline
1
E-GEOD-3720
cadmium chloride 2.5-hydrate
1
E-GEOD-6907
heregulin
1
E-GEOD-6462
nocodazole
1
E-GEOD-6431
37 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
E-GEOD-19519
DMSO
1
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-14359

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-2171, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-2191, E-GEOD-21374, ... (9 experiments)

Clinical treatment
studied in E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-3140, E-GEOD-2666, E-MTAB-62 ... (5 experiments)

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-22148, E-TABM-147, E-GEOD-21138, E-GEOD-3013 ... (5 experiments)

Environmental stress
studied in E-GEOD-1518, E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-4025, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (8 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-2466, E-GEOD-17476, E-GEOD-18005, E-TABM-601, ... (13 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-MEXP-2657, E-GEOD-20540, E-MEXP-1446, ... (10 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-974, E-MEXP-2069, E-GEOD-1926, ... (36 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, ... (8 experiments)

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977, E-MEXP-2177

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-22309, E-GEOD-21750, E-GEOD-6434, E-GEOD-1657

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-1880, E-GEOD-19445, ... (6 experiments)

Replicate
studied in E-GEOD-18791

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-1509, E-GEOD-1676, E-MEXP-101, ... (7 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-MEXP-70

Sex
studied in E-GEOD-1643, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-20114

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Test result
studied in E-GEOD-1926

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-16837, E-MEXP-973, E-GEOD-19246, ... (7 experiments)

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-TABM-43, E-GEOD-6532, E-GEOD-4922 ... (5 experiments)

Tumor size
studied in E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.436 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM